Diagnostic accuracy of18F Prostate Specific Membrane Antigen (PSMA) PET-CT radiotracers in staging and restaging of high-risk prostate cancer patients and patients with biochemical recurrence: protocol for an overview of reviews. This evidence concerns the gene FOLH1 and Familial prostate cancer.